TFF Pharmaceuticals (NASDAQ: TFFP)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-11 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.380 | -0.330 | 0.0500 | ||||
REV | 67.435K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of TFF Pharmaceuticals (NASDAQ: TFFP) through any online brokerage.
Other companies in TFF Pharmaceuticals’s space includes: Satsuma Pharmaceuticals (NASDAQ:STSA), Marinus Pharma (NASDAQ:MRNS), Incannex Healthcare (NASDAQ:IXHL), Harrow Health (NASDAQ:HROW) and Anebulo Pharmaceuticals (NASDAQ:ANEB).
The latest price target for TFF Pharmaceuticals (NASDAQ: TFFP) was reported by B. Riley Securities on Tuesday, March 29, 2022. The analyst firm set a price target for 18.00 expecting TFFP to rise to within 12 months (a possible 210.61% upside). 1 analyst firms have reported ratings in the last year.
The stock price for TFF Pharmaceuticals (NASDAQ: TFFP) is $5.795 last updated Today at July 5, 2022, 4:00 PM UTC.
There are no upcoming dividends for TFF Pharmaceuticals.
TFF Pharmaceuticals’s Q2 earnings are confirmed for Thursday, August 11, 2022.
There is no upcoming split for TFF Pharmaceuticals.
TFF Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.